Why do results conflict regarding the prognostic value of the methylation status in colon cancers? the role of the preservation method
<p>Abstract</p> <p>Background</p> <p>In colorectal carcinoma, extensive gene promoter hypermethylation is called the CpG island methylator phenotype (CIMP). Explaining why studies on CIMP and survival yield conflicting results is essential. Most experiments to measure D...
Main Authors: | Tournier Benjamin, Chapusot Caroline, Courcet Emilie, Martin Laurent, Lepage Côme, Faivre Jean, Piard Françoise |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-01-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/12/12 |
Similar Items
-
A case report of Muir-Torre syndrome in a woman with breast cancer and MSI-Low skin squamous cell carcinoma
by: Caroline Kientz, et al.
Published: (2017-05-01) -
Expression and Prognostic Characteristics of m6A RNA Methylation Regulators in Colon Cancer
by: Liting Huang, et al.
Published: (2021-02-01) -
School Conflicts, Spiral of Conflict and (Why Not?) Mediation
by: Klever Paulo Leal Filpo
Published: (2015-12-01) -
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
by: Laetitia Marisa, et al.
Published: (2013-01-01) -
Mother and offspring in conflict: why not?
by: Francisco Úbeda, et al.
Published: (2015-03-01)